Manara Michele, Aiolfi Alberto, Sozzi Andrea, Calì Matteo, Grasso Federica, Rausa Emanuele, Bonitta Gianluca, Bonavina Luigi, Bona Davide
I.R.C.C.S. Ospedale Galeazzi-Sant'Ambrogio, Division of General Surgery, Department of Biomedical Science for Health, University of Milan, Via C. Belgioioso, 173, 20157 Milan, Italy.
Department of Biomedical Sciences for Health, Division of General and Foregut Surgery, IRCCS Policlinico San Donato, University of Milan, 20097 Milan, Italy.
Cancers (Basel). 2024 Apr 23;16(9):1620. doi: 10.3390/cancers16091620.
Minimally invasive surgery for the treatment of locally advanced gastric cancer (AGC) is debated. The aim of this study was to execute a comprehensive assessment of principal surgical treatments for resectable distal gastric cancer.
Systematic review and randomized controlled trials (RCTs) network meta-analysis. Open (Op-DG), laparoscopic-assisted (LapAs-DG), totally laparoscopic (Lap-DG), and robotic distal gastrectomy (Rob-DG) were compared. Pooled effect-size measures were the risk ratio (RR), the weighted mean difference (WMD), and the 95% credible intervals (CrIs).
Ten RCTs (3823 patients) were included. Overall, 1012 (26.5%) underwent Lap-DG, 902 (23.6%) LapAs-DG, 1768 (46.2%) Op-DG, and 141 (3.7%) Rob-DG. Anastomotic leak, severe complications (Clavien-Dindo > 3), and in-hospital mortality were comparable. No differences were observed for reoperation rate, pulmonary complications, postoperative bleeding requiring transfusion, surgical-site infection, cardiovascular complications, number of harvested lymph nodes, and tumor-free resection margins. Compared to Op-DG, Lap-DG and LapAs-DG showed a significantly reduced intraoperative blood loss with a trend toward shorter time to first flatus and reduced length of stay.
LapAs-DG, Lap-DG, and Rob-DG performed in referral centers by dedicated surgeons have comparable short-term outcomes to Op-DG for locally AGC.
微创手术治疗局部进展期胃癌(AGC)存在争议。本研究的目的是对可切除远端胃癌的主要手术治疗方法进行全面评估。
系统评价和随机对照试验(RCT)网络荟萃分析。比较了开放远端胃癌切除术(Op-DG)、腹腔镜辅助远端胃癌切除术(LapAs-DG)、全腹腔镜远端胃癌切除术(Lap-DG)和机器人远端胃癌切除术(Rob-DG)。汇总效应量指标为风险比(RR)、加权平均差(WMD)和95%可信区间(CrIs)。
纳入10项RCT(3823例患者)。总体而言,1012例(26.5%)接受Lap-DG,902例(23.6%)接受LapAs-DG,1768例(46.2%)接受Op-DG,141例(3.7%)接受Rob-DG。吻合口漏、严重并发症(Clavien-Dindo>3级)和住院死亡率相当。在再次手术率、肺部并发症、需要输血的术后出血、手术部位感染、心血管并发症、清扫淋巴结数量和切缘无癌方面未观察到差异。与Op-DG相比,Lap-DG和LapAs-DG术中失血显著减少,首次排气时间有缩短趋势,住院时间缩短。
在转诊中心由专业外科医生进行的LapAs-DG、Lap-DG和Rob-DG治疗局部AGC的短期结局与Op-DG相当。